Medtronic (MDT): Fort Washington Investment Advisors Inc added to its stake +44K shares
Fort Washington Investment Advisors Inc added to its stake in Medtronic, per its Q4 2025 13F.
- 2.61M
- Shares reported · +44K vs prior quarter
- 1.3%
- Disclosed portfolio weight
- $250M
- Reported value
- Holdings as of
- Dec 31, 2025
- Filed
- Jan 13, 2026
What stands out in this filing
- 2,561,597 shares in Q3 2025, 2,605,343 now (+1.7% in share count).
- Reported at $250M, 1.33% of the portfolio value in this 13F filing.
- 63 other tracked managers reported the same kind of change for Q4 2025.
Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Nov 5, 2025CongressDisclosed purchase of MDT — reported range $1,001 - $15,000
- Nov 13, 2025CongressDisclosed partial sale of MDT — reported range $1,001 - $15,000
- Nov 18, 2025Company filing · Form 8-K · ResultsReported its results
- Nov 19, 2025Insider · 1 personInsiders: 7 sales (~$3.1M)
- Dec 3, 20255% stakeThe Vanguard Group reported a passive stake (13G) of 10.2%
- Dec 18, 2025CongressDisclosed sale of MDT — reported range $1,001 - $15,000
What came next
- Feb 5, 2026Layoff notice · 18000 Devonshire Street Northridge CA 91325Layoff notice filed in CA: 81 employees
- Feb 17, 2026Company filing · Form 8-K · ResultsReported its results
- Feb 19, 2026Insider · 1 personInsiders: 5 sales (~$5.1M)
- Mar 20, 2026CongressDisclosed sale of MDT — reported range $15,001 - $50,000
- Mar 27, 20265% stakeThe Vanguard Group reported a passive stake (13G)
- Apr 21, 2026FDAFDA device clearance: CD Horizon ModuLeX Fenestrated Screw Set; CD Horizon ModuLeX Spinal System
- Apr 21, 2026FDARecall: Medtronic DLP Retrograde Cannula Manual-Inflate Silicone Body 15FR, Model 94725; Cardiopulmonary bypass vascular catheter
- Apr 23, 2026FDAFDA device clearance: Elongated One-Piece Arterial (EOPA) 3D Arterial Cannulae
- Apr 23, 2026FDAFDA device clearance: Liberant RX Aspiration Catheter
- Apr 23, 2026FDARecall: Covidien Mon-a-Therm general purpose temperature probe size: 9 Fr REF: 90050
- Apr 23, 2026FDARecall: Covidien Shiley Disposable Decannulation Plug REF DDCP UDI-DI code: 10884522004060 Product Codes that include the Covidien Shiley Disposable Decannulation Plug…
- Apr 23, 2026FDARecall: Covidien Mon-a-Therm General Purpose Temperature Probe REF: 90044
- Apr 23, 2026FDARecall: Covidien Mon-a-Therm Esophageal Stethoscope with Temperature Sensor 400TM REF: 90042
- Apr 28, 20265% stakeVanguard Capital Management reported a passive stake (13G) of 7.5%
- May 1, 2026FDAFDA device clearance: Capnostream35 Portable Respiratory Monitor (PM35MN)
- May 12, 2026FDARecall: Octopus Evolution AS Tissue Stabilizer, Model TS2500
- May 12, 2026FDARecall: Octopus 4 Tissue Stabilizer, Model 29400
- May 12, 2026FDARecall: Octopus Evolution Tissue Stabilizer, Model TS2000
- May 13, 2026FDARecall: Medtronic 1x4 Pocket Adaptor Kit for Deep Brain Stimulation, Model 64001; Stimulator, electrical, implanted, for parkinsonian tremor
- May 13, 2026FDARecall: Medtronic 2x4 Pocket Adaptor Kit for Deep Brain Stimulation, Model 64002; Stimulator, electrical, implanted, for parkinsonian tremor
How to read SEC Form 13F-HR
Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.
Full guide: What is an SEC Form 13F?
What else is on file for Medtronic
For Medtronic, OQRO holds 6 insider filings (SEC Form 4 or Form 144), 1 Congress trade report and 1 fund holdings report (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its MDT page.
How this filing works
Explore the data
Common questions
What does this filing report about Medtronic (MDT) stock?
Fort Washington Investment Advisors Inc added to its stake in Medtronic, per its Q4 2025 13F. Now 2.61M shares, $250M reported value, 1.3% of disclosed portfolio.
When did it happen, and when was it made public?
Holdings as of: Dec 31, 2025. Filed: Jan 13, 2026.
What stands out in this filing?
2,561,597 shares in Q3 2025, 2,605,343 now (+1.7% in share count). Reported at $250M, 1.33% of the portfolio value in this 13F filing. 63 other tracked managers reported the same kind of change for Q4 2025.
Is this a trade made on a known date?
No. A holdings report is a picture of the portfolio on the last day of the quarter. It shows what was held on that day, not the day or the price at which anything was bought or sold.
Where does this information come from?
From the SEC Form 13F-HR, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about Medtronic recently?
For Medtronic, OQRO holds 6 insider filings (SEC Form 4 or Form 144), 1 Congress trade report and 1 fund holdings report (13F) dated in the last 90 days. They are listed on the MDT page.
Does this mean MDT stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Medtronic
- SEC Form 4Oct 16, 2026
- SEC Form 4Oct 16, 2026
- SEC Form 144Oct 15, 2026
- SEC Form 144Oct 15, 2026
- SEC Form 4Sep 18, 2026
- SEC Form 144Sep 16, 2026
Everything OQRO holds on this company is on its MDT page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
